Author:
LANSSENS D.,THIJS I.M.,GYSELAERS W.,II-CONSORTIUM PREMOM
Abstract
Pregnancy REmote MOnitoring: added value of remote monitoring in the prenatal care for women at risk for gestational hypertensive disorders
Worldwide, 5% to 8% of pregnancies are complicated with gestational hypertensive disorders (GHD), which are associated with a high maternal and neonatal morbidity and mortality. Observational data from the retrospective, non-randomized Pregnancy REmote MOnitoring (PREMOM I) study revealed potential benefits of remote monitoring (RM) in prenatal care of women at risk for GHD. When compared to conventional care, RM pregnancies showed a significant prolongation of pregnancy, a decrease in the total number of labour inductions and a clinically less severe form of GHD. A reduction in costs, due to less need for neonatal intensive care, was in balance with the cost for organisation and technology of RM. Based on this results, PREMOM II has been initiated: a prospective, randomized multicenter study, financed by the Research Foundation Flanders (FWO) to evaluate clinical, psychological and health economic performance of prenatal blood pressure RM.
Reference24 articles.
1. 1. Devlieger R, Goemaes R, Laubach M. Perinatale activiteiten in Vlaanderen 2019. Brussel: SPE, 2020.
2. 2. American College of Obstetricians and Gynecologists. Hypertension in pregnancy, 23 november 2015 (http://www.acog.org/Resources-And-Publications/TaskForce-and-Work-Group-Reports/Hypertension-in-Pregnancy).
3. 3. Abamas E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2014; 2: CD002252.
4. 4. Ankumah NA, Cantu J, Jauk V, et al. Risk of adverse pregnancy outcomes in women with mild chronic hypertension before 20 weeks of gestation. Obstet Gynecol 2014; 123: 966-972.
5. 5. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2003; 3: CD002863.